Ganges Health Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 10-01-2025
- Paid Up Capital ₹ 4.17 M
as on 10-01-2025
- Company Age 9 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.64 Cr
as on 10-01-2025
- Revenue 3576.27%
(FY 2019)
- Profit 5321.95%
(FY 2019)
- Ebitda 10316.98%
(FY 2019)
- Net Worth 243.20%
(FY 2019)
- Total Assets 570.71%
(FY 2019)
About Ganges Health Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.17 M.
The company currently has active open charges totaling ₹1.64 Cr.
Gargi Bhattacharya and Supriya Bhattacharya serve as directors at the Company.
- CIN/LLPIN
U74900WB2015PTC208978
- Company No.
208978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Hooghly, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ganges Health Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gargi Bhattacharya  | Director | 22-Dec-2015 | Current |
| Supriya Bhattacharya | Director | 22-Dec-2015 | Current |
Financial Performance of Ganges Health Biotech.
Ganges Health Biotech Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 3576.27% increase. The company also saw a substantial improvement in profitability, with a 5321.95% increase in profit. The company's net worth Soared by an impressive increase of 243.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ganges Health Biotech?
In 2019, Ganges Health Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Greenudyog Agro India Private LimitedActive 5 years 4 monthsGargi Bhattacharya and Supriya Bhattacharya are mutual person
- Swagnik Healthcare India Private LimitedActive 5 years 4 months
Gargi Bhattacharya and Supriya Bhattacharya are mutual person
- Muktesh Pharmaceuticals Private LimitedActive 3 years 9 months
Supriya Bhattacharya is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jan 2022 | ₹1.00 Cr | Open |
Axis Bank Limited Creation Date: 28 Apr 2021 | ₹2.39 M | Open |
Hdfc Bank Limited Creation Date: 31 Mar 2021 | ₹3.99 M | Open |
How Many Employees Work at Ganges Health Biotech?
Unlock and access historical data on people associated with Ganges Health Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ganges Health Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ganges Health Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
